Tarsus Pharmaceuticals Inc Cash Flow Quality Index
Tarsus Pharmaceuticals Inc cash flow quality index. Tarsus Pharmaceuticals Inc (TARS) has a Cash Flow Quality Index of 3.24x as of June 2021. Operating cash flow of $20.55 Million exceeds net income of $6.34 Million, indicating high earnings quality where cash backs reported profits. Explore TARS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tarsus Pharmaceuticals Inc Cash Flow Quality Index by Year (None–None)
Tarsus Pharmaceuticals Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Tarsus Pharmaceuticals Inc. For the full cash flow conversion analysis, see Tarsus Pharmaceuticals Inc cash conversion from operations.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|